Most existing fish vaccines are presented in the form of oil-based emulsions delivered by intraperitoneal injection. Whilst very effective they are frequently associated with inflammatory responses that can result in clinically significant side-effects often involving the adipose tissue that is in direct contact with the vaccine. To explore the potential of immune gene expression changes in the adipose tissue of fish to be markers of vaccination efficacy or development of side-effects we have studied the response to a bacterial (Aeromonas salmonicida) vaccine administered with two different adjuvants. The first adjuvant was Montanide™ ISA 763A VG, thought to induce a mostly humoral response, and the second was Montanide™ ISA 761 VG that gives a more balanced humoral and cell mediated response. Following vaccination tissue samples were collected at days 3, 14 and 28 for RTqPCR analysis. Fifty immune genes were studied with a focus on a) pro-inflammatory associated molecules and b) adaptive immune response related molecules linked with possible Th1, Th2, Th17 and Tregulatory pathways, with the expression data analysed for associations with Speilberg post-vaccination side effect scores. The results showed that the adipose tissue is a particularly sensitive and discriminatory tissue for studying adjuvant effects. A clear upregulation of many immune genes occurred in response to both vaccine groups, which persisted over time and overlapped with the appearance of visible adhesions. Our analysis revealed a relationship between adipose tissue immune function and the development of vaccine-induced adhesions giving the potential to use immune gene expression profiling in this tissue to predict the side-effects seen.
Introduction
Injectable water-in-oil emulsified vaccines have been used commercially in the aquaculture industry for more than two decades due to their cost effectiveness, stability, and ability to confer long term immunity (Brudeseth et al., 2013) . Most antigens used in fish vaccines are inactivated, based on killed pathogens or non-replicating pathogen subunits which require an adjuvant to trigger a strong enough response that will allow immunological memory to develop. While multivalent oil-adjuvanted vaccines produce long lasting protective immunity against a number of fish diseases, they can make a vaccine too reactogenic and are known to induce significant side effects in some of the vaccinated fish (Midtlyng et al., 1996a) . They are most likely to induce visible injection-site lesions, which are recognised grossly as melanisation and adhesions between internal organs or between the organs and the peritoneal wall (Midtlyng et al., 1996b) .
In mammals, adjuvanted vaccines mimic an infection and induce localized tissue responses which will elicit adequate and protective immune responses. They initiate the innate response, which will play a role in the activation of the adaptive immune response. For example, released pro-inflammatory cytokines will attract inflammatory cells and antigen presenting cells (APC), which will allow further priming of the immune responses by secretion of immunomodulatory cytokines. Maturation of APCs facilitates antigen presentation to T-cells, which when activated provide antigen specific help for B-cell proliferation and antibody production (Grun and Maurer, 1989) . Water-in-oil adjuvanted vaccines influence the antigen in time, place and concentration via the "depot effect". The vaccine emulsion forms a semi-solid mass at the injection site which releases the antigen slowly into the tissue or blood, enhancing and prolonging the humoral response (Cox and Coulter, 1997; Schijns, 2003) . It can also increase recruitment and activation of APCs at the injection site which leads to the stimulation of T-helper (Th) cells (Leroux-Roels, 2010) .
The fish immune system is comparable to that in mammals (Fletcher and Secombes, 2001; Pastoret et al., 1998) with similarities in the leukocyte types present, secreted humoral factors and cytokine regulation (Fletcher and Secombes, 2001; Secombes et al., 1996; Zou and Secombes, 2016) . However, whilst very effective vaccines exist for fish, such as those for rainbow trout and Atlantic salmon, we are only beginning to elucidate the innate and adaptive responses that lead to protective immunity following intraperitoneal injection of oil-adjuvanted bacterial vaccines (Bridle et al., 2011; Deshmukh et al., 2013; Jaafar et al., 2015; Kumari et al., 2013) . Furthermore, there are few studies that address the underlying mechanisms of induced side effects or inflammatory immunological reactions at a transcript level.
It is known that the peritoneal cavity of unvaccinated fish contains a mixed population of cells which include lymphocytes, macrophages and granulocytes (Afonso et al., 1997) . Injection of vaccines or other inflammatory agents into the peritoneal cavity of fish generates a change in composition as well as a rapid increase in the number of cells present (Korytář et al., 2013; Noia et al., 2014) . Work by Mutoloki et al. (2004) suggest that the persistence of antigens in the peritoneal cavity is associated with stimulation and maintenance of inflammatory reactions at the injection site of Atlantic salmon leading to adverse side-effects. While vaccine induced side effects tend to be localized to the point of injection, nevertheless the vaccine is disseminated from the injection site throughout the fish to different organs and tissues, where foreign body inflammatory reactions are initiated (Koppang et al., 2005) . However, it has been shown in rats that labelled mineral oil is distributed predominantly to the fat tissue (Bollinger, 1970) , which may explain the generalized and unpredictable adhesions in fish between visceral organs, visceral adipose tissue and the abdominal wall (which in teleosts also contains a large amount of lipids).
In mammals it has been recognized that visceral adipose tissue is a major immunologically active organ that contains immune cells (Kaminski and Randall, 2010) and is capable of influencing inflammation, secreting hormones, and pro-and anti-inflammatory proteins (Grant and Dixit, 2015; Mathis, 2013) . It has also been shown to play a role in the regulation of the peritoneal immune response to peritoneal antigens (Rangel-Moreno et al., 2009) . In fish, hints of an immune involvement of adipose have come from transcriptome studies of adipogenesis, where development of mature adipocytes is associated with high activity of immune genes in primary cultures of Atlantic salmon adipose stromo-vascular fraction cells and where exposure of cultured pre-adipocytes to LPS can induce expression of a range of immune genes, including the pro-inflammatory cytokine TNFα (Škugor et al., 2010) . More recently it has been demonstrated that teleost visceral adipose tissue can sequester particles from the peritoneum (Pignatelli et al., 2014) . This study confirmed the presence of a resident leukocyte population associated with the visceral adipose mass surrounding the digestive tract in fish; and also reported an immunological role for teleost visceral adipose tissue in response to viral challenge with modulation of cytokines, chemokines and toll-like receptors. (Pignatelli et al., 2014) .
To explore the potential to use immune gene expression changes in visceral adipose tissue as a marker of vaccination efficacy or development of side-effects, in the current study we have characterised the responses elicited in rainbow trout following intraperitoneal injection with two Aeromonas salmonicida vaccines containing different adjuvants. The first was a non-mineral oil based adjuvant expected to promote humoral immunity and the second was a mineral oil based adjuvant expected to promote both cell-mediated and humoral immunity. The responses measured included the expression of selected immune genes, coupled with serum antibody responses and visible side effects (adhesions) in the peritoneum. The two vaccines induced good humoral immunity and a wide range of innate and adaptive immune response related genes were modulated in adipose tissue, with prolonged and widespread changes of the gene set studied, confirming it is an important immune tissue in fish with a possible regulatory role. Inflammatory reactions in the form of granulatomous adhesions in the peritoneal cavity were detected with both vaccines following vaccination, and a relationship between vaccine-induced side effects and expression of immune related genes in the adipose tissue was established.
Materials and methods

Fish
Juvenile rainbow trout (Oncorhynchus mykiss) weighing approximately 60 g were purchased from College Mill Trout Farm (Perthshire, U.K.) and maintained in ∼400 L tanks at the University of Aberdeen aquarium facility, supplied with recirculating freshwater at 14°C. Fish were fed ad libitum daily with commercial pellets (EWOS) and were acclimated for at least two weeks prior to vaccination.
Vaccination
Two water-in-oil vaccine formulations were made, using as the aqueous phase of the vaccine a formalin-killed whole-cell Aeromonas salmonicida bacterin (pre-inactivation titre of 1.55 × 10 9 cfu/mL) suspended in BHI Media and provided by Elanco Animal Health Ltd. (Victoria, P.E.I., Canada). The first formulation used Montanide™ ISA 763A VG (SEPPIC) as an adjuvant, a commercially available non-mineral oil adjuvant that produces strong and long lasting protective immune responses in fish (Bastardo et al., 2012; Jaafar et al., 2015; Ravelo et al., 2006; Sitjà-Bobadilla et al., 2008) . The second used Montanide™ ISA 761 VG (SEPPIC), which as a mineral oil based adjuvant is thought to induce a more balanced cell mediated as well as humoral immune responses in higher vertebrates. The water-in-oil emulsions were prepared at a 70:30 oil:water ratio 48 h prior to vaccination using a high shear mixer (IKA Ultra Turrax Tube Drive), and were tested for stability prior to use. Fish were then anaesthetized with 2-phenoxyethanol (Fluka) and injected intraperitoneally (i.p.) with 0.1 mL of each formulation posterior to the pelvic girdle. Six treatment groups were examined during this study, as described in Table 1 .
Side effect scoring
Speilberg Standardized Extended Post-Vaccine Scoring was used to Molecular Immunology 88 (2017) 89-98 rank the severity of adhesions formed in the abdominal cavity at 7, 14, 28, 42 and 53 days post-vaccination (dpv). Adhesions were scored from 0 (no visible adhesions) to 6 (severe extensive lesions affecting nearly every internal organ in the abdominal cavity). The presence of visible vaccine remains (VVR) were noted as being present (1) or absent (0).
Tissue sampling, RNA extraction and cDNA synthesis
Visceral adipose tissue, located around the internal organs, was harvested from freshly killed trout (n = 5 per treatment group per time point) at 3, 14 and 28 dpv and snap frozen in dry ice. Adipose tissue (∼300 mg) was homogenized in 0.7 mL of TRI Reagent (Sigma) using a Qiagen Tissue Lyser II after which the samples were centrifuged and the oil layer removed as described previously . A further 0.7 mL of TRI Reagent was added followed by further homogenization, with the samples then stored at −80°C until RNA extraction. Total RNA was isolated following the manufacturer's guidelines. cDNA was synthesized using RevertAid reverse transcriptase (ThermoFisher) in 40 μL reactions as per the manufacturer's instructions, then diluted to 600 μL with T.E. buffer (pH 8.0) and stored at −20°C.
Real-time quantitative PCR (RTqPCR)
The expression of each gene was measured in duplicate as described previously (Hong et al., 2013; Wang et al., 2016) . RTqPCR was performed in a Roche LightCycler 480 using 2× SYBR Green RTqPCR Master Mix made with an Immolase DNA Polymerase kit (Bioline) with 10 μL reaction mixtures in 384-well plates (Roche). Data were analysed using LightCycler ® 480 Software 1.5.1 (Roche). All primers used for RTqPCR in this study are shown in Suppl. Table S1 . The relative expression level of each gene in tissues was expressed as arbitrary units that were calculated from the references and normalized against the expression level of the house keeping gene, elongation factor (EF)-1α as described previously (Wang and Secombes, 2008) . The levels of immune gene expression in each tissue was compared to that in the timematched control groups to determine if treatment had an effect on gene expression.
Gene expression
Fifty selected rainbow trout immune genes including acute phase proteins (APPs), antimicrobial peptides (AMPs), pro-and anti-inflammatory cytokines, cytokines of adaptive immunity, the IL-12 family cytokines and B cell markers were analysed. The APPs included cyclooxygenase (COX)-2 (Zou et al., 1999) ; Serum amyloid A (SAA); Serum amyloid P (SAP)-1 and -2. The AMPs analysed included Cathelicidin (CATH)-1 and -2 (Chang and Dong, 2007) and Hepcidin (Douglas et al., 2003) . The pro-and anti-inflammatory cytokines included the highly expressed IL-1β paralogue IL-1β1 (Husain et al., 2012) ; IL-6A (Iliev et al., 2007) and IL-6B; IL-8 (Liang et al., 2006) ; IL-11 (Wang et al., 2005) ; IL-18 (Zou et al., 2004) ; the four tumour necrosis factor-alpha (TNF-α) paralogues (TNF-α1-3, (Hong et al., 2013) ; TNF-α4, unpublished); two IL-10 paralogues (IL-10A and IL-10B) (Harun et al., 2011) , and transforming growth factor (TGF)-β1B (Maehr et al., 2013) . The cytokines of adaptive immunity included the key markers for Th1 (Interferon (IFN)γ1,2 (Zou et al., 2005) ); Th2 (IL-4/13A; IL-4/13B1,2, (Wang et al., 2016) and Th17 (the highly expressed IL-17A/F paralogues IL-17A/F1a; IL-17A/ F2a; IL-17A/F3 and IL-17N, Wang et al., 2015) ; and IL-22, (Monte et al., 2011) ) type responses. The subunits p40B1, p40C] , , IL-27 [p28A and B, and EBI3]) Jiang et al., 2015; (Wang et al., 2010b) , IL-21 and IL-34 . The B cells markers included membrane bound (m) and secreted (s) IgM and IgT (mIgM, mIgT, sIgM and sIgT). The forward and reverse specific primers used for each gene studied and their Accession nos. are reported in Suppl. Table S1 .
Blood sampling and ELISA
Blood was sampled from the caudal vein at 42 and 53 dpv, allowed to stand for 1 h at room temperature and then left overnight at 4°C. Blood was centrifuged (6,000 g, 20 min, 4°C) and sera extracted. Specific enzyme-linked immunosorbent assays (ELISA) were used to determine the A. salmonicida antibody titres. Antigen containing media used to formulate the vaccine was centrifuged (4,000 g, 15 min, 4°C) and washed 3 times in phosphate-buffered saline (PBS). The concentration of A. salmonicida was determined by wet pack cell mass weight, then the sample was re-suspended in PBS and briefly sonicated. The antigen was diluted to 20 μg/mL in coating buffer (carbonate bicarbonate buffer) (Sigma) and 50 μl was added to each well of a 96 well ELISA plate (Greiner). The plate was incubated at 37°C for 2 h, then 200 μL of PBS containing 5% (w/v) skimmed milk powder was added to each well and the plate incubated at 37°C for 2 h. The plate was washed 3 times using washing buffer (1% skimmed milk in PBS). Sera were serially diluted (2-fold) in washing buffer and 50 μL was added to each well and incubated overnight at 4°C. After washing 3 times in washing buffer 50 μl of anti-trout IgM (clone 4C10) (Thuvander et al., 1990 ) hybridoma supernatants were added to each well and incubated at 37°C for 2 h. The plate was then washed 3 times and 50 μl of alkaline phosphatase-conjugated goat anti-mouse IgG Fc specific antibody (1 in 3000 dilution in washing buffer) (Sigma) was added to each well and incubated at 37°C for 1 h. Lastly, the plate was washed 3 times and 50 μL of P-nitrophenyl phosphate (1 mg/mL) (Sigma) was added to each well. The plate was left to develop at room temperature in the dark for 30 min and read using Softmax Pro 5.3 (ELISA endpoint) in a spectrophotometer (Spectra max Plus, Analytical Technologies). For each serum sample, the highest dilution which still read as positive (2× negative control values) was taken as the titre.
Statistical analysis
Relative immune gene expression values were normalized against the house keeping gene EF-1α and log2 transformed prior to statistical analysis (as described in Wang et al., 2011) . Differential gene expression was assessed within each tissue by fitting a linear model with treatment as explanatory variables for each time point. When significant treatment effects were detected, group means of ADJ1, ADJ2, VAC1, VAC2 and AG were compared to the CTRL group post hoc using HSD tests. Model validation was performed by inspection of standard residual plots and considered significant when p < 0.05. Statistical significance of specific antibody titres in the treatment groups compared to the CTRL group was determined using Welches Two-sample ttest. Significant differences in the side effect score between treatment groups and time points were assessed using a Kruskal-Wallis test and Dunn's post hoc tests. In addition a linear discriminan analysis (LDA) was used to identify linear combinations of the fifty immune-related genes that discriminated between the different adhesion scores (0, 1, 2 or 3) in all treatment groups (n = 30) at 28 dpv. Expression data was mean centred and standardized to one unit standard deviation prior to analysis and LDA conducted using the MASS package (Venables and Ripley, 2002) . All statistical analysis was performed using the R statistical environment (version R-3.2.3., (R Development Core Team, 2016) ).
Results
Antibody response
To verify that the adjuvanted vaccines elicited strong antibody responses we first analysed the serum titres by ELISA. At 42 dpv, treatment groups VAC1, VAC2 and AG exhibited significantly higher antibody titres when compared to the CTRL group (Suppl. Fig. S1 ). The VAC1 and VAC2 groups also had significantly higher titres when compared to the AG group. At 53 dpv, treatment groups VAC1, VAC2 and AG again exhibited significantly higher antibody titres when compared to the CTRL group. The VAC1 and VAC2 titres were still significantly higher when compared to the AG group. There was no significant difference in titres between the VAC1 and VAC2 treatment groups at 42 dpv or 53 dpv but the anti-A. salmonicida titres at 53 dpv were significantly higher than at 42 dpv, with a marked increase in antibody titres commonly seen between these timings in rainbow trout (Riley and Secombes, 1996) .
Side effects
We next established whether the adjuvanted vaccines induced visible side effects, and if there were any differences seen between these two formulations (Fig. 1) . Overall vaccination-induced adhesion scores for both vaccine groups fell within industry-accepted limits for oil-adjuvanted fish vaccines. There was a 77% correlation between adhesions and visible vaccine remains at 28 dpv, a 43% correlation at 42 dpv, and a 45% correlation at 53 dpv. Using the Kruskal-Wallis test, followed by a Dunn's Multiple Comparison Test, to compare all treatment groups at each time point, a significant difference was found between 7 dpv and 53 dpv (p < 0.001) in terms of side effects. When comparing ADJ1, ADJ2, VAC1 and VAC2 there was a significant difference between VAC1 side effects compared to ADJ1 and ADJ2 side effects (p < 0.01 and p < 0.05 respectively), as well as a difference between VAC2 and ADJ1 (p < 0.05). There was no significant difference between ADJ2 and VAC2, or VAC1 and VAC2. No side effects were observed at any time point in the AG only treatment group.
Gene expression
The average fold change (n = 5 per group per time point) of the 50 genes studied at 3 time points post-vaccination is displayed in a heat map for adipose tissue (Fig. 2) , with gene values clustered by hierarchical clustering. A clear upregulation of many immune genes occurred in response to both vaccine groups and to some degree with the adjuvant only groups, which persisted over time and overlapped with the appearance of visible side effects (see above) allowing investigation of the relationship between these data sets in individual fish at the last time point used for gene expression analysis.
Within the adipose tissue, the genes which exhibited statistically significant changes in expression in response to VAC1 and/or VAC2, in relation to the CTRL group (treatment group effect) are displayed in Figs. 3-5 (a statistical summary for all genes examined in adipose tissue can be found in Suppl. Table S2 ). In general there was much overlap in the genes modulated in response to both vaccine groups, with most genes being upregulated within this tissue. The pro-inflammatory related cytokines IL-1β (Fig. 3A) , IL-6A (Fig. 3B) , IL-6B (Fig. 3C ), IL-8 (Fig. 3D) , IL-11 (Fig. 3E) , IL-18 (Fig. 3F) , TNF-α1 (Fig. 3G) , TNF-α2 (Fig. 3H ) and TNF-α3 (Fig. 3I) , and the APP and AMP genes SAA (Fig. 4A ), COX-2 (Fig. 4D) , CATH2 (Fig. 4C) and Hepcidin (Fig. 4E ) were all upregulated in adipose tissue in response to both vaccines with IL-8, SAA and CATH2 showing a statistically significant upregulation at all three time points post-vaccination. TNF-α3 was the most highly upregulated gene in adipose within all treatment groups (361 foldchange increase in response to VAC2 at 14 dpv). In contrast SAP2 was downregulated in adipose in response to VAC2 and AG only (Fig. 4B) . A number of cytokine genes associated with adaptive immunity were also significantly modulated. Several of the Th17 related genes were Fig. 1 . Side Effects Scores (adhesions) for individual fish (n = 6) in ADJ1 (Fig. 1A) , ADJ2 (Fig. 1B) , VAC1 (Fig. 1C) and VAC2 (Fig. 1D ) treatment groups at 7, 14, 28, 42 and 53 dpv. Bar = median. K.A. Veenstra et al. Molecular Immunology 88 (2017) 89-98 differentially expressed, with IL-17C1 (Fig. 4G ) and IL-17C2 (Fig. 4H ) upregulated by both vaccines, whilst IL-17D (Fig. 4I ) was downregulated at 28 dpv in response to VAC1/VAC2. IL-10A (Fig. 5A ), IL-15L (Fig. 5C ), p28A ( Fig. 5E ) and EBI3 (Fig. 5H ) were all upregulated in response to both vaccines, although not at all timings. Interestingly IFNγ2 (Fig. 5F ), IL-17A/F1a (Fig. 4F) , IL-22 (Fig. 5D ) and p35A1 ( Fig. 5G) were only upregulated by VAC1 at 28 dpv. Analysis of the Ig genes showed that both VAC1 and VAC2 significantly increased sIgM at 28 dpv (Fig. 5I ), in agreement with the ELISA data. There were only three genes found to be significantly increased in expression following AG alone; SAA and CATH2 at day 3, and SAA and EBI3 at day 14.
Linear discriminant analysis (LDA)
LDA was applied to assess the relationship between the adhesion scores and gene expression profiles. This method seeks the linear combination of variables that maximizes the ratio of between-group variance and within-group variance by using the grouping information. Implicitly, the linear weights used by LDA depend on how a gene separates the adhesion score groups and how this gene correlates with other genes.
Relative immune gene expression values of each individual in each treatment group were normalized against the housekeeping gene EF-1α and log2 transformed prior to analysis. LDA was applied to the 28 dpv data matrix of 30 samples; 5 fish per group for 6 experimental groups (ie all fish for which gene expression data was available). For the adipose tissue the first two linear discriminant analyses accounted for 89% of the variation at this time point. The biplot of the discriminant analysis indicates that individuals can be divided into four distinct groups based on their adhesions scores (Fig. 6 ) using differential gene expression in adipose tissue in response to all treatment groups at this time point. The calculated group-standardized variables are shown in Suppl. Table S3 . The ten genes with the highest absolute loadings were found to be: COX-2, IL-1β, IL-4/13B1, IL-6B, IL-10A, IL-17A/F1a, IL-21A, IL-27p28B, TGF-β1B, and EBI3. When the same analysis was applied to spleen expression data from the same fish at the same timing (28 dpv) no significant discrimination was found (first two linear discriminant analysis = 77%) (data not shown).
The LDA for adipose tissue was repeated using specific sub-sets (or combinations of sub-sets) of the 50 immune genes thought to be implicated in particular immune-regulatory pathways (eg pro-inflammatory or Th1, Th2, etc.) at 28 dpv but always resulted in poorer group segregation (data not shown).
Discussion
Early trials testing the efficacy of adjuvanted vaccines for use in Atlantic salmon farming found that whilst they are very effective often Fig. 2 . Average fold change of the 50 genes studied in ADJ1, ADJ2, VAC1, VAC2 and AG treatment groups in adipose tissue relative to control samples at 3, 14 and 28 dpv. Each column displays the average fold change (n = 5) and each row corresponds to the individual genes. Expression levels are colour coded relative to the control group: blue for downregulation, red for upregulation and white for no difference compared to the control. The dendrogram on the left illustrates the final clustering tree resulting from hierarchical clustering of gene values. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) K.A. Veenstra et al. Molecular Immunology 88 (2017) 89-98 induced visible injection-site intra-abdominal adhesions and pigmentation are apparent (Midtlyng et al., 1996b; Lillehaug et al., 1992) . Previous studies of such side-effects have focused mainly on their severity (Evensen et al., 2005; Midtlyng, 1996c) , histopathology (Larsen et al., 2014; Poppe and Breck, 1997) , antigen persistence (Mutoloki et al., 2004) , induction of autoantibodies (Satoh et al., 2011) and cell movement/cell composition within the peritoneal cavity (Korytář et al., 2003 , Mutoloki et al., 2004 . To date, there has been only one study on induced side effects or inflammatory immunological reactions at the transcript level in salmonids (Mutoloki et al., 2010) . In mammals, adipose tissue is increasingly seen as playing an important role in immune function. Numerous pro-inflammatory, antiinflammatory and immune-modulating proteins and peptides (in excess of 100) that belong to the cytokine, chemokine, complement and growth factor families have been identified in adipocytes (Schäffler and Schölmerich, 2010) . It is now recognised as a tissue that can influence and be influenced by adjacent and embedded lymphocytes (Pignatelli et al., 2014) . Despite evidence that persistent antigens of oil-based vaccines are associated with stimulation and maintenance of inflammatory reactions at the injection site of Atlantic salmon leading to adverse side-effects (Mutoloki et al., 2004) , and numerous studies identifying the adipose tissue surrounding the pyloric caeca as the main site of vaccine and adjuvant-only induced pigmentation and lesions (Villumsen et al., 2015) there have been no investigations of the relationship between immune and inflammatory responses within adipose tissue and vaccine induced side effects. Thus, in this study we have investigated for the first time the modulation of immune-related genes within rainbow trout adipose tissue in response to oil-adjuvanted i.p. vaccination and have explored whether a relationship exists between adipose tissue immune function and the development of vaccine-induced adhesions.
Two vaccines differing in their adjuvant component (VAC1-Montanide™ ISA 763A VG and VAC2-Montanide™ ISA 761 VG) were used in this study. Montanide™ adjuvants are a well-established brand of vaccine adjuvants currently used in industrial animal farming with diverse combinations of antigens (Aucouturier et al., 2000) . In fish, Montanide™ ISA 763A VG has been shown to give good protection when administered with salmon alphavirus (SAV) in Atlantic salmon (Thim et al., 2014) , and excellent protection when administered with Y. ruckeri in rainbow trout (Jaafar et al., 2015) . Both vaccines used in this (Fig. 3A) , IL-6A (Fig. 3B) , IL-6B (Fig. 3C ), IL-8 (Fig. 3D) , IL-11 (Fig. 3E) , IL-18 (Fig. 3F) , TNFα1 (Fig. 3G) , TNFα2 (Fig. 3H) and TNFα3 (Fig. 3I ) (mean + SE, n = 5 per treatment group per time point). All gene values were normalized against the house keeping gene EF-1α followed by normalization against the average relative expression of control group individuals. *** = p < 0.001; ** = p < 0.01; * = p < 0.05. Dark grey bars = VAC1, light grey bars = VAC2, white bars = AG. K.A. Veenstra et al. Molecular Immunology 88 (2017) 89-98 study induced a high antibody response against A. salmonicida, in comparison to control fish and those given A. salmonicida only (i.e. without adjuvant), suggesting both adjuvants were effective at promoting humoral responses. No significant difference in titres were found between the two vaccine groups, which showed a significant increase in titre with time, in agreement with the results of Romstad et al. (2012) where specific antibodies against A. salmonicida in Atlantic salmon peaked at 800-1000 degree days post-vaccination (corresponding to 56-70 dpv in this study). However, in contrast to the results of Jaafar et al. (2015) where injection of Montanide™ ISA 763A VG adjuvant alone induced high antibody levels against Y. ruckeri in rainbow trout, no antibody titres were detected in this study with either adjuvant tested in the absence of antigen. Since correlations have been found between the induction of specific circulating antibodies in trout and survival during experimental challenge to A. salmonicida (Romstad et al., 2013 (Romstad et al., , 2014 Villumsen et al., 2012) , our results suggests that both vaccines are likely efficacious against furunculosis. Our gene expression analysis showed that a large number of genes were found to be differentially regulated in the adipose tissue, especially the pro-inflammatory genes which were strongly upregulated in response to both adjuvanted vaccines throughout the time course. In contrast only a few of the genes studied were significantly modulated by the administration of adjuvant or antigen alone (see Suppl. Table  S2 ), hence the development of side-effects is likely the result of prolonged and widespread reaction to the co-administration of the oiladjuvant and bacterin in the adipose. The highest upregulated gene post-vaccination was TNF-α3 (360 fold change at 14 dpv in response to VAC2), with TNF-α1 and -α2 found to be upregulated to a lesser degree. In mammals, TNF is synthesised mainly by macrophages and monocytes but it can be secreted by T-helper cells (Brenchley et al., 2002) and it mediates crosstalk between adipocytes and macrophages (Mutoloki et al., 2010) . It has also been suggested it could be a key modulator of lipid metabolism in fish (Albalat et al., 2005) . Hong et al. (2013) demonstrated that recombinant TNF-α3 can induce expression of IL-1β, IL-6, IL-8, TNF-α and COX-2, and modulate the expression of IL-17C1, IL-17C2 and AMPs in trout. All of these genes were all found to be upregulated in both vaccine groups throughout the time course in the present study. Pignatelli et al. (2014) showed that TNF-α, IFNγ, IL-1β, (Fig. 4A), SAP2 (Fig. 4B), CATH2 (Fig. 4C ), COX-2 (Fig. 4D) , Hepcidin (Fig. 4E) , IL-17A/F1 (Fig. 4F) , IL-17C1 (Fig. 4G) , IL-17C2 (Fig. 4H ) and IL-17D (Fig. 4I ) (mean + SE, n = 5 per treatment group per time point). All gene values were normalized against the house keeping gene EF-1α followed by normalization against the average relative expression of control group individuals. *** = p < 0.001; ** = p < 0.01; * = p < 0.05. Dark grey bars = VAC1, light grey bars = VAC2, white bars = AG. K.A. Veenstra et al. Molecular Immunology 88 (2017) 89-98 IL-6 and IL-8 were upregulated in adipose tissue (likely in adipocytes) in response to viral infection, with IL-6 and IL-8 found to be modulated by adipose leukocytes. All of these genes were upregulated in trout adipose in response to the bacterial vaccines. Whilst in general terms both vaccines induced similar effects on innate responses in adipose tissue, it was of note that VAC1 had a greater impact on IL-17A/F1a, IL-18, IL-22, p35A1 and IFNγ2 expression relative to fish given VAC2, typically at 28 dpv. This suggests that at least in this tissue there may be a differential effect on cell-mediated immunity when using these two adjuvants, and warrants further study. The results of the LDA run on gene expression in adipose tissue at 28 dpv indicates for the first time that the adipose tissue may be a major contributor/driver of vaccine induced side effects in rainbow trout. That the LDA run on spleen gene expression data (data not shown) failed to discriminate between individuals expressing adhesions adds strength to this result. Not only was gene expression data able to differentiate between fish exhibiting no side-effects and those exhibiting side effects, but was also able to differentiate between those fish exhibiting variations in the severity of side effects. Further division of the 50 genes examined in this study into functional groups failed to discriminate in adipose tissue, however the group-standardized values do provide some intriguing insights into processes driving more severe adhesions. The highest absolute loadings (Suppl . Table S2 ) are the Th17-associated genes IL-17A/F1a and IL-21, along with the Treg associated TGF-β1B and IL-10A, and the IL-12 cytokine family genes IL27p28B and EBI3 that can potentially form a further negative regulator of T-cell responses, IL-27 (Vignali and Kuchroo, 2012) . Interestingly, IL-17A/F2 and TGF-β1A have previously been linked to severity of side effects in salmon, in microarray studies looking at gene expression changes in head kidney after vaccination with two different bivalent water-in-oil vaccines (Mutoloki et al., 2006) .
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